Lord’s Mark Industries Limited has announced the launch of the world’s first cost-optimised AI-powered hemodialysis centre at Shakti Hospital, Ahmedabad. The company disclosed the development under Regulation 30 of SEBI Listing Regulations on May 04, 2026.

The newly launched dialysis centre is powered by the Lord’s Renal Renalyx Machine, which the company described as India’s first indigenously developed smart AI-based hemodialysis system.

The development marks a significant step for the company in the healthcare technology and medical device manufacturing sector.

Renalyx machine developed under Make in India initiative

According to the company, the Renalyx Machine has been designed and developed in India as part of the government’s Make in India initiative.

The company stated that the dialysis system combines:

• Artificial Intelligence (AI)
• Internet of Things (IoT)
• Cloud connectivity
• Smart monitoring technologies

These technologies are aimed at improving dialysis treatment quality, operational efficiency, patient safety, and affordability.

The launch also reflects India’s growing capabilities in advanced medical technology manufacturing.

Key features of the AI-powered dialysis system

Lord’s Mark highlighted several advanced features integrated into the Renalyx Machine.

Personalized dialysis protocols

The machine uses AI-driven systems to customize dialysis treatment protocols according to patient-specific clinical requirements.

This approach may improve treatment precision and patient outcomes.

Kt/V tracking system

The system supports Kt/V tracking, which is an important parameter used to measure dialysis adequacy and treatment effectiveness.

Continuous tracking may help healthcare professionals optimize treatment quality.

Precise fluid management

The machine includes intelligent fluid management capabilities designed to improve dialysis efficiency while reducing complications related to fluid imbalance.

Endotoxin filtration technology

The Renalyx system also integrates endotoxin filtration technology, which enhances patient safety by improving water purification standards during dialysis procedures.

Remote supervision and centralized monitoring

One of the major advantages of the system is its cloud connectivity and centralized monitoring capability.

Doctors and healthcare administrators can remotely supervise treatment sessions and access patient data in real time through centralized digital systems.

This feature can improve operational efficiency across multiple dialysis centres.

Focus on affordability and scalability

The company stated that the AI-powered dialysis system has been designed with a strong focus on:

• Cost efficiency
• Scalability
• Clinical effectiveness
• Healthcare accessibility

The management believes the technology can help lower the total cost of ownership for hospitals and healthcare providers while expanding access to quality dialysis treatment.

India faces a large demand-supply gap in dialysis treatment infrastructure, particularly in smaller cities and semi-urban regions. Affordable and scalable dialysis systems may help address this challenge.

Strategic importance for India’s medical device sector

Lord’s Mark stated that the launch of the Renalyx Machine may help reduce India’s dependence on imported dialysis equipment.

Currently, a significant portion of advanced dialysis systems used in India are imported from global manufacturers. Indigenous manufacturing could help lower costs and improve supply chain reliability.

The company also stated that the project strengthens India’s position in:

• Advanced medical device manufacturing
• AI-based healthcare technologies
• Digital healthcare infrastructure

The launch aligns with India’s broader objective of increasing domestic manufacturing capabilities in the healthcare and medical technology sector.

Expansion plans announced

Lord’s Mark Industries has announced aggressive expansion plans for its dialysis business.

The company plans to establish:

• 50 dialysis centres by March 2027

In addition to expanding dialysis centres domestically, the company also plans to focus on:

• Domestic sales of Renalyx Machines
• Export opportunities
• International market expansion

The management stated that the company is currently in the process of obtaining US FDA approval for the Renalyx Machine.

FDA approval could become an important milestone for global commercialization and exports.

Management commentary on the launch

Commenting on the development, Mr. Sachidanand Upadhyay, Managing Director of Lord’s Mark Industries Limited, stated that the Renalyx Machine represents a transformational step in dialysis treatment.

According to him, the integration of intelligent technology, indigenous manufacturing, and affordability can improve dialysis accessibility while supporting India’s emergence as a global leader in AI-based medical devices.

The management also highlighted the company’s long-term focus on innovation-led healthcare solutions.

Importance of AI in dialysis treatment

Artificial Intelligence is increasingly being integrated into healthcare systems worldwide.

In dialysis treatment, AI technologies can support:

• Predictive patient monitoring
• Real-time treatment optimization
• Automated data analysis
• Reduced human errors
• Better resource utilization

AI-based dialysis systems may improve treatment quality while helping healthcare institutions manage operational costs more efficiently.

The integration of cloud technology and IoT devices also supports centralized patient management and data-driven clinical decision-making.

Growing dialysis demand in India

India has witnessed increasing demand for dialysis treatment due to:

• Rising chronic kidney disease cases
• Increasing diabetes prevalence
• Aging population
• Better healthcare awareness

However, access to affordable dialysis infrastructure remains a challenge in many regions.

The government and private healthcare providers are increasingly focusing on expanding dialysis networks and improving healthcare accessibility.

Technology-driven solutions such as AI-powered dialysis systems could play an important role in addressing these challenges.

Potential opportunities for Lord’s Mark

The company’s expansion into AI-based dialysis technology may create several growth opportunities in the coming years.

Potential growth drivers include:

• Expansion of dialysis centre networks
• Government healthcare initiatives
• Growing demand for affordable treatment
• Export opportunities in emerging markets
• Adoption of AI-driven healthcare infrastructure

If the company successfully scales operations and secures regulatory approvals, it could strengthen its position in India’s healthcare technology market.

Challenges and execution risks

Despite strong opportunities, the company may also face several challenges, including:

• Regulatory approvals
• Technology adoption risks
• Competition from global medical device companies
• Capital expenditure requirements
• Operational scaling challenges

Successful execution, service reliability, and product acceptance among hospitals will remain important factors for long-term growth.

Healthcare technology becoming major investment theme

The healthcare technology sector is attracting increasing investor interest globally.

Areas such as:

• AI-driven diagnostics
• Smart medical devices
• Telemedicine
• Remote patient monitoring
• Digital healthcare infrastructure

are witnessing rapid development and investment activity.

India’s growing healthcare needs and digital infrastructure expansion are also supporting the long-term growth potential of the sector.

Lord’s Mark’s latest initiative reflects the increasing convergence of healthcare, AI, and domestic manufacturing capabilities.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.